A Clinical Study With Adalimumab Biosimilar

NCT06291948 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics
Safety Issues

Interventions

BIOLOGICAL: Humira® (adalimumab) AC Pen [Reference Product]
BIOLOGICAL: Adalimumab Richmond [Test Product]

Sponsor

Laboratorios Richmond S.A.C.I.F.

Collaborators

[object Object]
[object Object]